
Venture capital · Early stage
Aglaia
Dutch venture investor dedicated to cancer therapeutics, creating and funding young companies that develop oncology drugs. It states that it is not currently considering new opportunities.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Aglaia right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (ESMA register).
Latest investments
Rounds Aglaia joined, from press and the firm’s own posts.
Every round Aglaia joined
Round sizes, Aglaia’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company Aglaia backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Aglaia
Events where Aglaia’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Aglaia is based in the Netherlands. It also has an office in Bilthoven.
2 fund vehicles are on public registers (ESMA register), including Aglaia Oncology Fund III Coöperatieve U.A. and Aglaia Oncology Growth Opportunity Fund II Coöperatieve U.A.
Stages: Early stage. Sectors: Biotech, Life sciences. From the firm’s own website.
Seeks promising early inventions that could change how cancer is treated, then matures them into clinical-stage businesses. The team brings long oncology R&D experience, shapes strategy together with founders and helps plan research from first screening through clinical trials, aiming to reach licensing, sale or listing. From the firm’s own website.
Aglaia lists 9 portfolio companies on its website, including Cristal Therapeutics, Inthera Bioscience, Mimetas, Modra and Sapreme Technologies.
Firms whose websites list some of the same companies include Avoro Capital Advisors, BIG VENTURES MANAGEMENT COMPANY, LLC and RA Capital.
Know before Aglaia’s next round is announced.
PRO tracks Aglaia’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.